Walgreens New Decentralized Clinical Trials Model in Action
The 2024 SCOPE Summit, a pivotal event in clinical trials, showcased innovative strategies to transform patient recruitment and trial...
Unpacking FDA’s New Guidance on Facilitating Understanding in eConsent
Informed consent is not just a procedural formality but a basis of ethical practice, ensuring that participants fully understand...
FDA Approves Breyanzi® as First CAR-T Therapy for CLL/SLL
Bristol Myers Squibb announced the accelerated FDA approval of Breyanzi® (lisocabtagene maraleucel; liso-cel), a CD19-directed chimeric antigen receptor (CAR)...
Single Sign-On Technology: Easing Study Site Burden Now
In the intricate and rapidly evolving landscape of clinical trials, integrating efficient and cutting-edge technology solutions has become a...
Stanford’s New Leap in Personalized Medicine and Trials
The forefront of personalized medicine is dramatically reshaped by advancements in biomarker discovery and digital health technologies (DHTs) –...
Pfizer’s Phase 3 Trial Shows Positive Survival in DLBCL
Pfizer Inc. has announced promising Phase 3 study results for ADCETRIS® (brentuximab vedotin) in combination with lenalidomide and rituximab...
Merck Successfully Acquires Harpoon Therapeutics, Inc.
Merck has successfully completed the acquisition of Harpoon Therapeutics, Inc., making Harpoon a wholly-owned subsidiary of Merck. As a...
Digital Health Technologies: New Era in Clinical Research
Digital health technologies (DHTs) are revolutionizing the landscape of clinical research, pushing us toward more innovative and patient-centered trial...
Remarkable Edge in Cancer Vaccine Treatment: New Hope
In this interview, we engage with Andrew Allen, a pioneering force in the field of immunotherapy and the co-founder...
Viiv Healthcare Presents Promising Cabenuva Data at CROI
ViiV Healthcare has announced promising interim data from the LATITUDE phase III trial, presented at the CROI 2024. The...